Clinical potential of targeting Bruton's tyrosine kinase.
about
Inhibitors of BTK and ITK: state of the new drugs for cancer, autoimmunity and inflammatory diseases.Role of Bruton's tyrosine kinase in myeloma cell migration and induction of bone diseaseIdentification of a Btk-BAG3 complex induced by oxidative stress.Role of Bruton's tyrosine kinase in macrophage apoptosis.
P2860
Clinical potential of targeting Bruton's tyrosine kinase.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical potential of targeting Bruton's tyrosine kinase.
@en
Clinical potential of targeting Bruton's tyrosine kinase.
@nl
type
label
Clinical potential of targeting Bruton's tyrosine kinase.
@en
Clinical potential of targeting Bruton's tyrosine kinase.
@nl
prefLabel
Clinical potential of targeting Bruton's tyrosine kinase.
@en
Clinical potential of targeting Bruton's tyrosine kinase.
@nl
P2860
P1476
Clinical potential of targeting Bruton's tyrosine kinase.
@en
P2860
P356
10.1080/08830180701784588
P577
2008-01-01T00:00:00Z